EGFR and neoplasm: Gene set enrichment analysis between the high- and low-risk groups revealed that tumor-related pathways, including adherens junction, ErbB, mTOR and WNT signaling pathways, renal cell carcinoma, and ubiquitin-mediated proteolysis were obviously enriched.